Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
UnitedHealth Group Incorporated is a healthcare plans business based in the US. UnitedHealth Group Incorporated shares (UNH) are listed on the NYSE and all prices are listed in US Dollars. UnitedHealth Group Incorporated employs 330,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$412.34|
|52-week range||$285.53 - $429.85|
|50-day moving average||$416.96|
|200-day moving average||$398.85|
|Wall St. target price||$461.86|
|Dividend yield||$5.2 (1.25%)|
|Earnings per share (TTM)||$15.14|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-15)||-1.24%|
|1 month (2021-08-20)||-4.04%|
|3 months (2021-06-22)||3.42%|
|6 months (2021-03-22)||12.40%|
|1 year (2020-09-22)||40.13%|
|2 years (2019-09-20)||77.05%|
|3 years (2018-09-21)||54.63%|
|5 years (2016-09-22)||192.36%|
Valuing UnitedHealth Group Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of UnitedHealth Group Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
UnitedHealth Group Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, UnitedHealth Group Incorporated shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
UnitedHealth Group Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5459. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into UnitedHealth Group Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
UnitedHealth Group Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $23.1 billion.
The EBITDA is a measure of a UnitedHealth Group Incorporated's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$272.1 billion|
|Operating margin TTM||7.68%|
|Gross profit TTM||$67 billion|
|Return on assets TTM||6.48%|
|Return on equity TTM||21.11%|
|Market capitalisation||$396.2 billion|
TTM: trailing 12 months
There are currently 6.4 million UnitedHealth Group Incorporated shares held short by investors – that's known as UnitedHealth Group Incorporated's "short interest". This figure is 3% down from 6.6 million last month.
There are a few different ways that this level of interest in shorting UnitedHealth Group Incorporated shares can be evaluated.
UnitedHealth Group Incorporated's "short interest ratio" (SIR) is the quantity of UnitedHealth Group Incorporated shares currently shorted divided by the average quantity of UnitedHealth Group Incorporated shares traded daily (recently around 2.2 million). UnitedHealth Group Incorporated's SIR currently stands at 2.96. In other words for every 100,000 UnitedHealth Group Incorporated shares traded daily on the market, roughly 2960 shares are currently held short.
However UnitedHealth Group Incorporated's short interest can also be evaluated against the total number of UnitedHealth Group Incorporated shares, or, against the total number of tradable UnitedHealth Group Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case UnitedHealth Group Incorporated's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 UnitedHealth Group Incorporated shares in existence, roughly 10 shares are currently held short) or 0.0068% of the tradable shares (for every 100,000 tradable UnitedHealth Group Incorporated shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against UnitedHealth Group Incorporated.
Find out more about how you can short UnitedHealth Group Incorporated stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like UnitedHealth Group Incorporated.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 20.65
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and UnitedHealth Group Incorporated's overall score of 20.65 (as at 12/31/2018) is pretty good – landing it in it in the 25th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like UnitedHealth Group Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 0.53/100
UnitedHealth Group Incorporated's environmental score of 0.53 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that UnitedHealth Group Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 14.36/100
UnitedHealth Group Incorporated's social score of 14.36 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that UnitedHealth Group Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 4.76/100
UnitedHealth Group Incorporated's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that UnitedHealth Group Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. UnitedHealth Group Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that UnitedHealth Group Incorporated hasn't always managed to keep its nose clean.
|Total ESG score||20.65|
|Total ESG percentile||24.52|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
|Level of controversy||3|
Dividend payout ratio: 33.67% of net profits
Recently UnitedHealth Group Incorporated has paid out, on average, around 33.67% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.39% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), UnitedHealth Group Incorporated shareholders could enjoy a 1.39% return on their shares, in the form of dividend payments. In UnitedHealth Group Incorporated's case, that would currently equate to about $5.2 per share.
While UnitedHealth Group Incorporated's payout ratio might seem fairly standard, it's worth remembering that UnitedHealth Group Incorporated may be investing much of the rest of its net profits in future growth.
UnitedHealth Group Incorporated's most recent dividend payout was on 20 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 September 2021 (the "ex-dividend date").
UnitedHealth Group Incorporated's shares were split on a 2:1 basis on 30 May 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your UnitedHealth Group Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for UnitedHealth Group Incorporated shares which in turn could have impacted UnitedHealth Group Incorporated's share price.
Over the last 12 months, UnitedHealth Group Incorporated's shares have ranged in value from as little as $285.5284 up to $429.8462. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while UnitedHealth Group Incorporated's is 0.7702. This would suggest that UnitedHealth Group Incorporated's shares are less volatile than average (for this exchange).
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
Everything we know about the Wetouch Technology IPO, plus information on how to buy in.
Everything we know about the Life Time Group Holdings IPO, plus information on how to buy in.
Everything we know about the Slinger Bag IPO, plus information on how to buy in.
Everything we know about the NSTS Bancorp IPO, plus information on how to buy in.
Everything we know about the Volcon IPO, plus information on how to buy in.
Everything we know about the Thomas James Homes IPO, plus information on how to buy in.
Everything we know about the FGI Industries IPO, plus information on how to buy in.
Everything we know about the Zhong Yang Financial Group IPO, plus information on how to buy in.
Everything we know about the Exscientia Ltd IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.